 | Panel seeks more data on Serum Institute's EUA application for Covovax useThe SII had last month submitted an application to the Drugs Controller General of India (DCGI) seeking emergency use authorisation (EUA) for Covovax's use among children in the age group. |
 | Serum Institute, Bharat Biotech cut COVID vaccine prices for private hospitals to Rs 225The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose. |
 | Biological E Ltd to get mRNA technology from WHO to produce COVID-19 vaccinesA press release from BE Limited said the WHO's Advisory Committee on Vaccine Product Development (ACPDV) selected the firm after examining a number of proposals from India. |
 | Covid-19: Centre considering booster dose for Indians travelling abroadThe Centre may soon allow a precaution dose of Covid-19 vaccine for those seeking to travel abroad for education, employment, sports and for attending official or business commitments. |
 | TS has over 6.66 L doses of CovaxinMeanwhile, the State has about 6.66 lakh doses of Covaxin available at its cold chain points and at district vaccine stores. |
 | Decision on mixing and matching of booster dose of Covid vaccines will be based on science: GovernmentOn the Corbevax vaccine, VK Paul said it will find a way into the national vaccination programme as an order has been placed and delivered for a certain quantity. |
 | Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age groupThe Corbevax vaccine is administered through intramuscular route with two doses scheduled 28 days apart and presented as 0.5 ml (single dose) and 5 ml (10 doses) vial pack. |
 | Vaccine effectiveness of 99.3 per cent seen in fully vaccinated: MandaviyaICMR has developed the India Covid-19 Vaccine Tracker, by merging mainly three national databases -- CoWIN, National Covid-19 Testing database and Covid-19 India portal. |
 | Sputnik V Covid vaccine shows higher Omicron-specific antibodies than Pfizer: StudyThe joint Russian-Italian study compared the blood serum samples of people taken three to six months after the second dose of the two vaccines. |
 | CM Bommai launches COVID-19 vaccine drive for children in KarnatakaIn Bengaluru, BBMP has planned the vaccination in 196 schools (49639 beneficiaries) and 59 colleges (22067 beneficiaries) on day one, spread out across eight zones |
 | COVID jab: Bengaluru Urban excluding BBMP sees 129% first dose coverage, 100% second dose coverageBBMP's vaccination coverage, however, is below the state average of 75 percent for two doses |
 | US Army develops single vaccine to fight against all Covid variantsWithin weeks, Walter Reed researchers expect to announce that human trials show success against Omicron — and even future strains. |
 | Puducherry to insist on COVID-19 vaccine certificates for New Year celebrationsTo make the celebrations safe, hotels, lodges, homestays and guesthouses have been directed to insist upon vaccination certificates for tourists who check in, said the Puducherry Tourism Minister |
 | Elders can take J&J vaccine booster two months after first vaccine shot: RegulatorThe European Medicines Agency also said the J&J vaccine can be used as a booster dose in people who have had two shots of the vaccines made by Pfizer and Moderna. |
 | India's COVID-19 booster dose policy will be in line with WHO's, says CentreThe world health body so far has been vehemently opposing booster doses for the general population, while endorsing it for those with serious immuno-suppression |
